LicciardiLab

Half the funding. Half the future. The Medical Research Future Fund was meant to deliver $1B each year — only $650M is reaching researchers. Join the call to release the full funds now. aamri.org.au/mrff #releasethefullmrff @Mark_Butler_MP @JEChalmers

How multidisciplinary scientists & policy makers can work together to translate new knowledge into policy using a learning health systems approach Our 2nd Forum On PCV Access and Sustainability hosted by our @nhmrc Centre for Research Excelkence mcri.edu.au/news/events/as…

In 2024, nearly 38 million children under five were acutely malnourished across 26 nutrition crises. “We cannot respond to empty stomachs with empty hands and turned backs.” - @antonioguterres Learn more. ⬇️

One dose of the human papillomavirus (HPV) #vaccine is just as effective in providing long-term immune protection against #cervicalcancer as a two or three dose schedule, a new #MCRI-led study finds. 👉 nature.com/articles/s4146… @LicciardiLab @ZhengQToh @qChauQuang

@KllN349312 @MCRI_for_kids @CEPIvaccines Longitudinal analysis out to 12m post vaccination is ongoing, stay tuned.

@MCRI_for_kids @CEPIvaccines Why do so many studies look at 28 days? How does it look like at 90 days?

A new MCRI study found that as a 4th dose, Moderna boosted more #antibodies than Novavax but also caused more side effects. However, both #vaccines activated the immune system in a similar way. Read more ➡️ doi.org/10.1016/j.jinf… @CEPIvaccines

MCRI's Dr Nadia Mazarakis said both vaccines produced similar T-cell responses (a key part of your immune system that protects you from harmful viruses). The findings could help inform ongoing #booster strategies.

Our latest research on single dose #HPV vaccination just published @NatureComms -supports one dose strategy using systems serology rdcu.be/eb1cs Great team science @ZhengQToh @AmyWChung and our PhD student @qChauQuang and everyone else involved @MCRI_for_kids @UniMelb

In an unprecedented move, research-grant reviews have been suspended indefinitely at the world’s largest public funder of biomedical research go.nature.com/4gclXG0

Respiratory syncytial virus (RSV) is a major cause of illness and death in infants and older adults. A Review in @TheLancetInfDis discusses the different RSV vaccines available and emphasizes the need to ensure these vaccines reach the most vulnerable: hubs.li/Q030TKl10

Our ⁦@nhmrc⁩ CRE developed a new collaboration with ⁦@SirirajMedicine⁩ Thailand Our 2 vs 3 PCV dose noninferiority RCT using the more affordable ⁦⁦@SerumInstIndia⁩ has recruited 100 in 3w 🎉 ⁦@LicciardiLab⁩ ⁦@CSatzke⁩ ⁦@MCRI_for_kids⁩

A new #MCRI led study has found that fewer doses of #pneumococcal vaccines were just as effective at providing sustained immunity among Vietnamese babies. @MenziesResearch @darrens_ong @LicciardiLab @ThanhPh32823293 @ZhengQToh @MulhollandKim 👉 nature.com/articles/s4146…

Our recent preprint by postdoc Nadia Mazarakis is out on evaluation of SARS-CoV-2 antibody responses in adults and children using a novel microsampling device doi.org/10.1101/2024.0… Great to have the collaboration with @trajanscimed @SynexaLS @MCRI_for_kids @ZhengQToh

The Melbourne Vaccine Education Centre is inviting healthcare professionals to join an upcoming clinical vaccinology update on RSV at @RCHMelbourne on June 21. | #MCRI #RSV #Vaccination #InfectiousDisease @MVECau Register ➡️ mvec.mcri.edu.au/events/cvu-min…

Now hiring to a project officer role for the PROPHECY study. Large MRFF funded clinical and scientific collaboration studying COVID vaccine responses in high risk populations.@PROPHEC19 livehire.com/job/alfredheal… monash.edu/medicine/proph…

MCRI's @DanielPellicci has been awarded a Viertel Senior Medical Research Fellowship. This #research could help reduce the severity of #Tuberculosis, #StrepA and #RSV - and pave the way for future #vaccines. Read more👉mcri.edu.au/news/awards/fe…

Is the Novavax COVID Vaccine Better than mRNA Vaccines? What We Know So Far - Scientific American scientificamerican.com/article/is-the…

Excited to share this work, led by @sam_manna3 with @markushilty, Joel & Neil, together with @stephlo_lo @LicciardiLab @BelindaOrtika @Eliza__Nikolaou @Fiona_M_Russell @MulhollandKim @emd3737 & many more not on twitterX especially our colleagues Drs Odgerel & Tuya #Mongolia

Great to be part of #C192023! Zheng Quan Toh and Nadia Mazarakis presenting their work on COVID-19 vaccine immune responses in kids and adults @ASHMMedia @MCRI_for_kids

Researchers have made a breakthrough in understanding how a specific type of #ImmuneCell defends against #infection and #disease! The study, co-led by Murdoch Children's, found promising discoveries that could result in better preventive treatments. 🔗➡️mcri.edu.au/news-stories/d…